Ascendis Pharma A/S
Ascendis Pharma A/S (ASND) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
asnd · stock forecast · 25 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 25 Wall Street analysts in the past 3 months
Buy
25 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$345
Consensus
$288
+36.6% upside
Low
$250
Median: $267.5 · Last Close: $210.45
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$287.50
36.6% upside
High Target
$345
63.9%
Low Target
$250
18.8%
Current Price
$210.45
as of today
Based on analyst price targets, the ASND stock price prediction for the next 12 months ranges from $250 to $345. The consensus ASND price forecast of $287.50 implies 36.6% upside from the current price of $210.45.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $200.13 | ↓ 4.91% |
1-day model range: $199.19–$201.06. Peak: $201.06 (-4.91%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $257 | +22.3% |
| 2028 | $295 | +40.0% |
| 2029 | $323 | +53.2% |
| 2030 | $342 | +62.6% |
| 2031 | — | +69.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ASND · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-11 | Barclays | Maintains | Overweight→Overweight |
| 2026-05-08 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-04-16 | B of A Securities | Maintains | Buy→Buy |
| 2026-04-09 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-03 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-02-12 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-12 | Wedbush | Maintains | Outperform→Outperform |
| 2026-01-30 | B of A Securities | Maintains | Buy→Buy |
| 2026-01-20 | Wells Fargo | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Ascendis Pharma A/S (ASND) stock. Of the recent 214 rating actions, 6 were upgrades and 6 were downgrades. 25 analysts currently cover ASND.
Analyst Recommendation Trends
ASND analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.3B
↓ 45.1% YoY
Revenue Next Year
$1.9B
↑ 44.4% YoY
EPS This Year
$13.52
EPS Next Year
$9.47
↓ 30.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ASND EPS of $13.52 for the current fiscal year, based on estimates from 10 analysts. The ASND revenue forecast is $1.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ASND stock forecast is supported by two independent data sources: analyst consensus ratings from 25 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ASND price target is $287.50 (+36.6% upside), with an analyst consensus of Buy.
The ASND short-term stock prediction for tomorrow is $200.13 (-4.91%). The ASND stock price prediction for 2027 estimates an average of $257. The ASND stock prediction for 2030 projects a range of $325–$360.
Ascendis Pharma A/S trades on NASDAQ under the ticker ASND. The ASND stock outlook for 2027 is broadly positive, supported by a Buy consensus among 92% of covering analysts.
Frequently asked questions
ASND forecast · 8 questionsAccording to 25 Wall Street analysts, the average 12-month ASND price target is $287.50, with a high forecast of $345.00 and a low of $250.00. The median price target is shown in the chart above when available. This implies +36.6% potential upside from the current price of $210.45.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.